The DP receptor, allergic inflammation and asthma

被引：60

作者：

Kabashima, K ^{[1
]}

Narumiya, S ^{[1
]}

机构：

[1] Kyoto Univ, Fac Med, Dept Pharmacol 2, Sakyo Ku, Kyoto 6068501, Japan

来源：

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2003年 / 69卷 / 2-3期

关键词：

prostaglandin D-2; DP; allergy; inflammation; asthma; conjunctivitis; colitis; skin; pain; sleep;

D O I：

10.1016/S0952-3278(03)00080-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Prostaglandin (PG) D-2 is the major cyclooxygenase metabolite of arachidonic acid produced by mast cells in response to allergen in diseases, such as asthma, atopic dermatitis, allergic rhinitis and allergic conjunctivitis. However, whether PGD(2) regulates allergic process per se, and, if so, whether it facilitates or down-regulates the disease process has remained unknown. PGD(2) exerts its actions by binding to two types of specific cell surface receptor. One is DP (the PGD receptor) and the other is chemoattractant receptor-homologous molecule expressed on Th2. Between the two, the DP receptor has been better characterized since its cDNA cloning in 1994, and novel class of DP antagonists have been and are being developed. Furthermore, mice deficient in DP were generated and have been subjected to several models of allergic diseases to reveal the role of PGD(2) in allergy. In this article, we summarize these findings and provide an overview of the current status of the DP receptor research to discuss the therapeutic potential of modulating the PGD(2)-DP pathway in allergic diseases. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

页码：187 / 194

页数：8

共 58 条

[1]

Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238

[2]

ALJARAD N, 1994, BRIT J CLIN PHARMACO, V37, P97

[3] Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection [J].

Angeli, V ;

Faveeuw, C ;

Roye, O ;

Fontaine, J ;

Teissier, E ;

Capron, A ;

Wolowczuk, I ;

Capron, M ;

Trottein, F .

JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (10) :1135-1147

[4]

Arimura A, 2001, J PHARMACOL EXP THER, V298, P411

[5] Dendritic cells and the control of immunity [J].

Banchereau, J ;

Steinman, RM .

NATURE, 1998, 392 (6673) :245-252

[6] THE RELEASE OF PROSTAGLANDIN-D2 FROM HUMAN-SKIN INVIVO AND INVITRO DURING IMMEDIATE ALLERGIC REACTIONS [J].

BARR, RM ;

KORO, O ;

FRANCIS, DM ;

BLACK, AK ;

NUMATA, T ;

GREAVES, MW .

BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (03) :773-780

[7] EFFECT OF HISTAMINE AND OTHER MAST-CELL MEDIATORS ON T84 EPITHELIAL-CELLS [J].

BARRETT, KE .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 664 :222-231

[8] MOLECULAR-CLONING AND CHARACTERIZATION OF THE HUMAN PROSTANOID DP RECEPTOR [J].

BOIE, Y ;

SAWYER, N ;

SLIPETZ, DM ;

METTERS, KM ;

ABRAMOVITZ, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :18910-18916

[9] Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells [J].

Chan, CL ;

Jones, RL ;

Lau, HYA .

BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) :589-597

[10] CUTANEOUS LATE-PHASE RESPONSE IN FOOD-ALLERGIC CHILDREN AND ADOLESCENTS WITH ATOPIC-DERMATITIS [J].

CHARLESWORTH, EN ;

KAGEYSOBOTKA, A ;

NORMAN, PS ;

LICHTENSTEIN, LM ;

SAMPSON, HA .

CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (05) :391-398

← 1 2 3 4 5 6 →